Skip to main content
. 2022 Mar 14;12(6):2833–2859. doi: 10.7150/thno.70719

Table 3.

Bacteria/Fungi/Protozoa in TME and their potential functions and therapeutics

Bacteria/Fungi/Protozoa Tumor Function Therapeutic approach Ref
Bacteria Anaerococcus mediterraneensis Colorectal cancer Unknown 96
Bacillus cereus Colorectal cancer Unknown 96
Bacteroides fragilis Colorectal cancer Unknown 96
Enterococcus faecalis Colorectal cancer Unknown 96
Escherichia coli Colorectal cancer and liver metastasis Unknown 96
Fusobacterium hwasookii Colorectal cancer Unknown 96
Fusobacterium nucleatum Colorectal cancer Oncogenic Antibiotics 107
Klebsiella pneumoniae Colorectal cancer and liver metastasis Unknown 96
Porphyromonas gingivalis Colorectal cancer Unknown 96
Prevotella denticola Colorectal cancer Unknown 96
Streptococcus anginosus Colorectal cancer Unknown 96
Streptococcus pneumoniae Colorectal cancer Unknown 96
Fungi Ascomycota Pancreatic ductal adenocarcinoma Unknown 111
Basidiomycota Pancreatic ductal adenocarcinoma Unknown 111
Candida albicans Renal cell carcinoma; squamous cell carcinom Oncogenic 109
Malassezia globosa Pancreatic ductal adenocarcinoma Oncogenic 111
Protozoa Toxoplasma gondii Brain, lung, prostate, cervix, and endometrial cancers Oncogenic Anti-Toxoplasma drugs 112